Company Filing History:
Years Active: 2012-2017
Title: Emily Stanley: Innovator in Autotaxin Inhibitors
Introduction
Emily Stanley is a prominent inventor based in Horsham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of autotaxin inhibitors. With a total of 5 patents to her name, her work is paving the way for new treatments in various medical conditions.
Latest Patents
Emily's latest patents focus on novel compounds that act as autotaxin inhibitors. The first patent describes compounds of formula (I) that are autotaxin inhibitors, detailing processes for their preparation, pharmaceutical compositions, and medicaments containing them. This invention is aimed at treating diseases or conditions that are dependent on or mediated by autotaxin. The second patent also relates to autotaxin inhibitors, emphasizing their use in treating disorders mediated by autotaxin.
Career Highlights
Emily Stanley is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals.
Collaborations
Some of her notable coworkers include David Beattie and Andrew James Culshaw. Their collaboration has further enhanced the innovative research environment at Novartis.
Conclusion
Emily Stanley's contributions to the field of autotaxin inhibitors highlight her role as a key innovator in pharmaceuticals. Her patents and ongoing work continue to influence the development of new treatments for various medical conditions.